2019
DOI: 10.1007/s00464-019-07138-6
|View full text |Cite
|
Sign up to set email alerts
|

Reduction of invasive interventions in severely obese with osteoarthritis after bariatric surgery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
1
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(2 citation statements)
references
References 21 publications
0
1
0
1
Order By: Relevance
“…Weight-loss options include lifestyle changes (diet and/or exercise), weight-loss medications, and bariatric surgery (5). Currently, bariatric surgery results in the greatest excess weight loss in persons with class III obesity and can be accompanied by additional health benefits, including mortality reduction and type knee pain, weight loss can reduce knee pain and improve function, potentially reducing the need for TKR (7,8). While the value of TKR has been established (1,2), the value of weight-loss interventions prior to TKR has received little study.…”
Section: Introductionmentioning
confidence: 99%
“…Weight-loss options include lifestyle changes (diet and/or exercise), weight-loss medications, and bariatric surgery (5). Currently, bariatric surgery results in the greatest excess weight loss in persons with class III obesity and can be accompanied by additional health benefits, including mortality reduction and type knee pain, weight loss can reduce knee pain and improve function, potentially reducing the need for TKR (7,8). While the value of TKR has been established (1,2), the value of weight-loss interventions prior to TKR has received little study.…”
Section: Introductionmentioning
confidence: 99%
“…En el caso de la DM2, se definió mejoría como la disminución del uso de medicación ya sea en las dosis o fármacos empleados y remisión como el abandono definitivo de la medicación con una concentración de hemoglobina glicosilada (HbA1c) inferior a 6.5 %; para la HTA y trastornos lipídicos se definió mejoría como la disminución del uso de medicación ya sea en dosis o cantidad de fármacos empleados, y remisión como el abandono definitivo de la medicación con cifras normales de presión arterial o lípidos séricos. Para trastornos respiratorios, enfermedades osteomusculares, trastornos gastrointestinales y trastornos cardiovasculares diferentes de hipertensión no existen escalas universales sino son dependientes de la enfermedad en específico por lo que se tomó como mejoría la disminución de medicación o intervenciones para su control y como remisión el cese de sintomatología sin apoyo farmacológico [17][18][19][20][21][22][23]. También se describieron complicaciones postquirúrgicas tempranas, medidas con la escala de Clavien Dindo, misma que ha sido validada en estudios anteriores [24].…”
Section: Introductionunclassified